FindMyRecallSubscribe
Class I: serious health riskTerminated

Town and Country Compounding and Consultation Services Sermorelin/GHRP-6 Injection 6 mg-3 mg Recall

Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Co…

Town and Country Compounding and Consultation Services · Ridgewood, NJ

Risk level
Class I
Reported by FDA
Dec 28, 2016
Recall ID
D-0228-2017
Check your lot numberHow we source this data

Summary

Town and Country Compounding and Consultation Services recalled Sermorelin/GHRP-6 Injection 6 mg-3 mg starting Aug 1, 2016. The FDA classified it as Class I (serious health risk) and published enforcement report D-0228-2017 on Dec 28, 2016. Reason: Non-Sterility; microbial contamination identified as Bacillus circulans. Status: Terminated.

Why it was recalled

Non-Sterility; microbial contamination identified as Bacillus circulans

Product description

Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502

Lot numbers, UPCs & expiration codes

lot #07172016@1, exp 1/13/2017

Where it was sold

MA, NY, NJ & FL; Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0228-2017
Classification
Class I
Status
Terminated
Recall initiated
Aug 1, 2016
FDA report date
Dec 28, 2016
Quantity
12 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Town and Country Compounding and Consultation Services

Original FDA data

Every field from FDA enforcement report D-0228-2017, exactly as published.

Show all FDA fields
City
Ridgewood
State
NJ
Status
Terminated
Country
United States
Event ID
74938
Address
106 Prospect St
Code information
lot #07172016@1, exp 1/13/2017
Postal code
07450-4433
Report date
Dec 28, 2016
Product type
Drugs
Recall number
D-0228-2017
Classification
Class I
Recalling firm
Town and Country Compounding and Consultation Services
Product quantity
12 vials
Termination date
Oct 8, 2019
Reason for recall
Non-Sterility; microbial contamination identified as Bacillus circulans
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
Distribution pattern
MA, NY, NJ & FL; Canada
Recall initiation date
Aug 1, 2016
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Dec 22, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0228-2017, published Dec 28, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls